Poultry Diagnostic Testing Market Size & Share Analysis - Growth Trends And Forecast (2024 - 2031)
By Test;
ELISA Test, PCR Test, Complement Fixation Test, Immuno-Fluorescent Antibody Test (IFAT), Indirect Hemagglutination Test (IHA), Direct Agglutination Test and Other Diagnostic TestsBy Disease;
Avian Salmonellosis, Visceral Leishmaniasis (Kala-Azar), Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Avian Pasteurellosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Encephalomyelitis, Avian Reovirus and Chicken AnemiaBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Poultry Diagnostic Testing Market Overview
Poultry Diagnostic Testing Market (USD Million)
Poultry Diagnostic Testing Market was valued at USD 1,044.82 million in the year 2024. The size of this market is expected to increase to USD 1,241.62 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 2.5%.
Poultry Diagnostic Testing Market
*Market size in USD million
CAGR 2.5 %
| Study Period | 2026 - 2032 |
|---|---|
| Base Year | 2025 |
| CAGR (%) | 2.5 % |
| Market Size (2025) | USD 1,044.82 Million |
| Market Size (2032) | USD 1,241.62 Million |
| Market Concentration | High |
| Report Pages | 317 |
Major Players
- IDEXX Laboratories, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Zoetis, Inc.
- GD Animal Health
- IDvet
- AffiniTech, LTD.
- AgroBioTek Internacional
- BioNote, Inc.
- BioChek
- Boehringer Ingelheim
- MEGACOR Diagnostik GmbH
- BioinGentech Biotechnologies
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Poultry Diagnostic Testing Market
Fragmented - Highly competitive market without dominant players
Poultry Diagnostic Testing Market is witnessing strong growth, driven by the rising incidence of infectious diseases in poultry populations. More than 65% of poultry farms are adopting diagnostic solutions to detect health threats early. With biosecurity becoming a top concern, preventive strategies are taking center stage. These conditions are fostering fresh opportunities for diagnostic innovators aiming to deliver faster and more accurate testing systems.
Preventive Testing Becoming Industry Norm
Preventive diagnostics now account for over 60% of poultry testing applications, marking a shift from reactive care to continuous health surveillance. This change is fueling demand for cost-effective and fast-response testing kits. Emphasis on proactive intervention strategies is supporting better animal welfare and overall productivity. This shift continues to shape the growth trajectory of the diagnostic testing space.
Innovation in Tools Enhancing Accuracy and Speed
Ongoing technological advancements are redefining efficiency in poultry diagnostics. Tools like real-time PCR and smart biosensors have enhanced testing precision by 55%, making disease detection quicker and more reliable. AI-driven analytics are further optimizing these systems, offering actionable insights for farmers and labs alike. These innovations are crucial for strengthening the future outlook of modern poultry care frameworks.
Robust Investment Supporting Expansion Plans
The outlook for Poultry Diagnostic Testing Market remains strong, with over 58% of poultry operations planning infrastructure upgrades. Increased focus on R&D, coupled with rising concerns about animal health, is pushing demand for portable and easy-to-use testing tools. A wave of innovation, smart regulation, and evolving strategies is expected to unlock sustained expansion in the coming years.
Poultry Diagnostic Testing Market Key Takeaways
-
Growing global emphasis on biosecurity and disease surveillance is boosting adoption of rapid diagnostic assays for avian pathogens.
-
Emergence of molecular diagnostics such as PCR and RT-PCR has revolutionized early detection accuracy for avian influenza and Newcastle disease.
-
Integration of point-of-care testing kits in hatcheries enables real-time monitoring, minimizing outbreak-related losses.
-
Government programs and OIE-aligned regulations promote standardized testing to safeguard poultry trade integrity.
-
Automation in ELISA platforms supports high-throughput analysis for vaccine efficacy tracking.
-
Private veterinary networks increasingly partner with diagnostic laboratories for rapid result delivery and digital reporting.
-
Emerging markets in Asia and Latin America show significant expansion owing to intensive broiler production growth.
Poultry Diagnostic Testing Market Recent Developments
-
In July 2018, Zoetis, an animal healthcare company, announced a new vaccine dose called Poulvac Procerta HVT-IBD-ND, which protects against three diseases — Marek’s, Newcastle, and bursal infections. To expand its position in veterinary diagnostics, Zoetis also finalized the acquisition of Abaxis, a global leader in veterinary point-of-care testing tools.
-
In March 2018, BioChek released the Salmonella Enteritidis-Typhimurium-Heidelberg DNA Test Kit and the Infectious Bronchitis Virus RNA Test Kit for identification in avian samples.
Poultry Diagnostic Testing Market Segment Analysis
In this report, the Poultry Diagnostic Testing Market has been segmented by Test, Disease, and Geography.
Poultry Diagnostic Testing Market, Segmentation by Test
The Test segmentation identifies the key diagnostic methods used in poultry disease detection. These tests include ELISA Test, PCR Test, Complement Fixation Test, Immuno-Fluorescent Antibody Test (IFAT), Indirect Hemagglutination Test (IHA), Direct Agglutination Test, and Other Diagnostic Tests. Each of these tests offers different levels of sensitivity, specificity, and applications in disease diagnosis within poultry populations.
ELISA Test
The ELISA (Enzyme-Linked Immunosorbent Assay) test is widely used due to its high sensitivity and ability to detect specific antibodies in poultry. It is commonly used for diagnosing diseases like avian influenza, avian mycoplasmosis, and salmonellosis, providing accurate results quickly, making it a staple in poultry disease testing.
PCR Test
The PCR (Polymerase Chain Reaction) test is used to detect the genetic material of pathogens in poultry. It is highly sensitive and can detect the presence of pathogens even at low concentrations. PCR is commonly used for diagnosing diseases such as avian influenza and Newcastle disease, where rapid detection is essential.
Complement Fixation Test
The Complement Fixation Test (CFT) is used for detecting antibodies against certain diseases, especially avian influenza and infectious bursal disease. It works by assessing the reaction between the complement and the antigen-antibody complex, which is a key marker in disease diagnosis.
Immuno-Fluorescent Antibody Test (IFAT)
The Immuno-Fluorescent Antibody Test (IFAT) is utilized to detect specific antigens in poultry samples. By using fluorescent-labeled antibodies, IFAT helps identify the presence of diseases like avian reovirus and avian encephalomyelitis, enabling precise diagnostics at the cellular level.
Indirect Hemagglutination Test (IHA)
The Indirect Hemagglutination Test (IHA) is commonly used to detect antibodies for avian diseases, such as Newcastle disease and avian salmonellosis. It is a cost-effective and relatively simple test, making it suitable for widespread use in poultry farms and diagnostic labs.
Direct Agglutination Test
The Direct Agglutination Test detects the presence of pathogens in poultry by examining how antigens react with antibodies in a sample. It is frequently used for diagnosing bacterial infections like avian pasteurellosis and salmonellosis, where quick results are needed for effective management.
Other
This category encompasses various alternative and emerging diagnostic techniques, such as lateral flow assays and molecular probes, that may offer faster results or be more suitable for specific poultry diseases. These tests are expanding as diagnostic technology improves and new disease strains emerge.
Poultry Diagnostic Testing Market, Segmentation by Disease
The Disease segmentation covers the major diseases affecting poultry and the corresponding diagnostic testing methods used to detect them. Key diseases include Avian Salmonellosis, Visceral Leishmaniasis (Kala-Azar), Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Avian Pasteurellosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Encephalomyelitis, Avian Reovirus, and Chicken Anemia. These diseases pose significant threats to the poultry industry, impacting production and the quality of poultry products.
Avian Salmonellosis
Avian salmonellosis is a bacterial infection that affects poultry, leading to symptoms such as diarrhea, fever, and reduced egg production. Diagnostic tests like ELISA and PCR are commonly used to detect this disease, which poses a significant risk to poultry farming and public health due to zoonotic transmission.
Visceral Leishmaniasis (Kala-Azar)
Visceral Leishmaniasis (Kala-Azar) is a parasitic disease that can affect poultry, causing weight loss and organ failure. It is primarily diagnosed through serological tests such as ELISA and PCR, which help in identifying the parasite’s genetic material or antibodies in the infected birds.
Avian Influenza
Avian influenza, commonly known as bird flu, is one of the most devastating diseases in poultry. It is diagnosed using PCR and serological tests like ELISA and IFAT. Early detection of this disease is crucial for controlling outbreaks and preventing the spread to humans and other animals.
Newcastle Disease
Newcastle disease is a viral infection that can cause severe respiratory and neurological symptoms in poultry. PCR and serological tests, such as the Complement Fixation Test, are commonly used to confirm the presence of this disease in poultry populations.
Avian Mycoplasmosis
Avian mycoplasmosis is caused by bacterial infection and leads to respiratory issues in poultry. ELISA and PCR are frequently employed for diagnosis, as these tests help detect the presence of mycoplasma bacteria in poultry flocks, leading to more effective management and treatment.
Avian Pasteurellosis
Avian pasteurellosis is a bacterial infection that results in severe pneumonia in poultry. It is commonly diagnosed using serological tests such as Indirect Hemagglutination Tests (IHA), along with PCR for more precise detection of the Pasteurella bacteria.
Infectious Bronchitis
Infectious bronchitis is a viral respiratory disease in poultry that affects egg production. PCR and ELISA are used for its detection, helping in identifying the virus early to prevent further spread in commercial flocks.
Infectious Bursal Disease
Infectious bursal disease is a viral infection that targets the immune system of poultry. PCR and ELISA are essential diagnostic tools used to detect the presence of the virus and assess its impact on the poultry’s immune function.
Avian Encephalomyelitis
Avian encephalomyelitis affects the nervous system of poultry and leads to tremors and incoordination. It is diagnosed through PCR tests, which help detect the viral RNA, and serological tests like ELISA that identify antibodies against the virus.
Avian Reovirus
Avian reovirus causes enteric and respiratory diseases in poultry. It is diagnosed using PCR and ELISA tests to detect the virus in poultry fecal samples or blood, enabling prompt intervention to manage outbreaks.
Chicken Anemia
Chicken anemia is a viral infection that weakens the immune system in poultry, leading to lethargy and reduced egg production. It is diagnosed using PCR and immunoassays to detect the virus in blood samples from infected birds.
Poultry Diagnostic Testing Market, Segmentation by Geography
The Geography segmentation divides the market into key regions such as North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Regional dynamics influence market growth, including differences in poultry farming practices, regulatory frameworks, and disease prevalence.
Regions and Countries Analyzed in this Report
North America
North America represents a dominant share of poultry diagnostic testing market, driven by strong healthcare systems, advanced veterinary services, and a significant poultry farming industry. The prevalence of poultry diseases and the demand for diagnostic tests to ensure food safety drive market growth in this region.
Europe
Europe has a well-established market for poultry diagnostics, driven by stringent regulatory frameworks and large-scale poultry farming operations. The growing focus on animal welfare and food safety further fuels the demand for diagnostic testing solutions across the region.
Asia Pacific
Asia Pacific is expected to experience the fastest growth in poultry diagnostic testing market, as poultry farming practices evolve and the demand for diagnostics increases. Countries like China and India, with large poultry industries, are key markets for diagnostic tests to address diseases and ensure public health safety.
Middle East & Africa
The Middle East & Africa market is growing steadily due to increasing awareness of poultry disease management and government efforts to improve poultry health systems. The demand for diagnostic testing is rising as countries in this region invest in enhancing their veterinary healthcare infrastructure.
Latin America
Latin America shows moderate growth in poultry diagnostic testing market, driven by rising poultry production and the need for improved disease control and management practices. Poultry health issues, such as avian influenza, are prompting governments and industries to adopt more widespread diagnostic testing.
Poultry Diagnostic Testing Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Poultry Diagnostic Testing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development | |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers :
- Increasing Poultry Product Demand
- Poultry Disease Awareness
- Disease Management Necessity
-
Advanced Diagnostic Technologies - Advanced diagnostic technologies have revolutionized the field of veterinary medicine, particularly in poultry health management, offering unprecedented capabilities in disease detection, monitoring, and control. These cutting-edge technologies leverage molecular, immunological, and imaging techniques to provide accurate, rapid, and comprehensive diagnostic insights, empowering veterinarians and poultry producers to make informed decisions and implement targeted interventions.
One of the most significant advancements in poultry diagnostic testing is the Polymerase Chain Reaction (PCR) technology, which allows for the amplification and detection of specific nucleic acid sequences of pathogens with remarkable sensitivity and specificity. PCR assays enable the rapid identification of viral, bacterial, and fungal pathogens, even at low concentrations, facilitating early disease detection and control. Moreover, real-time PCR platforms provide quantitative results, allowing for the precise monitoring of disease progression and treatment efficacy in poultry populations.
Another key technology is Enzyme-Linked Immunosorbent Assay (ELISA), which detects and quantifies specific antibodies or antigens in poultry samples. ELISA assays are highly sensitive, enabling the detection of immune responses to pathogens and the assessment of vaccine efficacy in vaccinated flocks. These tests play a crucial role in serological surveillance, disease monitoring, and vaccination programs, supporting proactive disease management strategies in poultry farming.
Immunofluorescence microscopy and immunohistochemistry are advanced imaging techniques used to visualize and identify pathogens in tissue samples. These techniques utilize fluorescent-labeled antibodies to target specific antigens or antibodies, providing detailed insights into the localization and distribution of pathogens within infected tissues. Immunofluorescence and immunohistochemistry are invaluable tools for diagnosing complex diseases such as avian influenza, Newcastle disease, and infectious bronchitis, facilitating accurate disease characterization and epidemiological investigations.
Restraints :
- High Cost of Diagnostic Tests
- Limited Access in Rural Areas
- Lack of Skilled Personnel
-
Technological Limitations - Technological limitations in poultry diagnostic testing can present challenges that hinder the effectiveness and accessibility of diagnostic solutions. These limitations encompass various aspects of technology development, implementation, and utilization, impacting the accuracy, speed, cost-effectiveness, and scalability of diagnostic tests. Key technological limitations include.
Certain diagnostic technologies may require specific infrastructure, such as laboratory facilities or cold chain storage, for proper operation and maintenance. Inadequate infrastructure can pose logistical challenges and limit the scalability of diagnostic testing programs, particularly in remote or underserved areas.
Proper sample collection, handling, and transport are critical for ensuring the accuracy and reliability of diagnostic test results. However, logistical constraints, such as limited access to refrigeration or transportation facilities, can compromise sample integrity and lead to inaccurate test outcomes.
Adequate technical support and training are essential for ensuring the effective implementation and utilization of diagnostic technologies. However, limited access to training programs and ongoing technical support can hinder the capacity of personnel to perform diagnostic tests accurately and interpret results correctly.
Addressing these technological limitations requires ongoing research and development efforts to improve the sensitivity, specificity, speed, and accessibility of diagnostic tests. Additionally, investment in infrastructure development, training programs, and technology transfer initiatives can enhance the capacity of poultry producers and veterinarians to implement and utilize advanced diagnostic technologies effectively. By overcoming these limitations, stakeholders can ensure the availability of accurate, timely, and cost-effective diagnostic solutions to support the health and productivity of poultry populations worldwide.
Opportunities :
- Emerging Markets Expansion
- Technological Innovations
- Increased Investment in R&D
-
Growing Demand for Rapid Diagnostic Tests - The growing demand for rapid diagnostic tests (RDTs) in poultry health management reflects a broader trend towards more efficient and responsive disease detection strategies. Rapid diagnostic tests offer several key advantages over traditional diagnostic methods, including speed, simplicity, portability, and accessibility. These attributes make RDTs particularly well-suited for addressing the urgent need for timely disease detection and control in poultry farming.
One of the primary drivers behind the increasing demand for RDTs is the critical importance of early disease detection in mitigating the spread of infectious diseases within poultry populations. Rapid diagnostic tests provide results in a matter of minutes to hours, enabling prompt intervention measures such as quarantine, treatment, and vaccination to be implemented before disease outbreaks escalate. This rapid response capability is essential for minimizing economic losses, preventing the spread of disease to neighboring farms, and safeguarding public health.
RDTs offer significant benefits in terms of simplicity and ease of use, making them accessible to a wide range of end-users, including poultry producers, farm workers, and veterinarians. Unlike laboratory-based tests that require specialized equipment and trained personnel, many RDTs can be performed on-site using simple procedures and minimal training, eliminating the need for sample transportation and centralized laboratory facilities. This decentralized approach to diagnostic testing enhances the agility and responsiveness of disease surveillance programs, particularly in remote or resource-limited areas where access to laboratory infrastructure may be limited.
Portability is another key advantage of RDTs, allowing for diagnostic testing to be conducted directly at the point of care, whether in the field, on the farm, or at the slaughterhouse. Portable RDT devices are compact, lightweight, and battery-operated, enabling rapid deployment and use in diverse settings without the need for external power sources or specialized laboratory environments. This portability enhances the versatility and scalability of diagnostic testing programs, enabling real-time monitoring of poultry health and disease status across different geographic regions and production systems.
Poultry Diagnostic Testing Market Competitive Landscape Analysis
Poultry Diagnostic Testing Market presents a competitive landscape shaped by veterinary innovation, disease control strategies, and strategic partnerships among diagnostic kit manufacturers, poultry producers, and research laboratories. Leading players hold nearly 65% of total market share, focusing on molecular testing, ELISA-based assays, and portable diagnostic solutions. Expanding collaboration with veterinary institutions and biosecurity firms continues to drive growth in disease detection and monitoring systems across poultry operations.
Market Structure and Concentration
The market demonstrates moderate consolidation, with top manufacturers contributing approximately 60% of total revenue. Companies employ strategies centered on early disease detection, high-throughput analysis, and automation in testing workflows. Ongoing collaboration with research organizations and veterinary associations supports technological advancements in PCR, immunodiagnostics, and next-generation sequencing for avian health diagnostics.
Brand and Channel Strategies
Manufacturers are enhancing brand positioning through specialized distribution channels and partnerships with poultry farms, veterinary clinics, and government agencies. Nearly 55% of market participants maintain partnerships with regional veterinary distributors and diagnostic laboratories. These strategies improve testing accessibility, promote preventive healthcare, and expand product adoption across small-scale and industrial poultry production.
Innovation Drivers and Technological Advancements
Approximately 70% of R&D efforts focus on technological advancements in point-of-care testing, rapid molecular assays, and multiplex diagnostic kits. Continuous innovation enhances detection speed, pathogen specificity, and field usability. Strategic collaboration with biotech firms and veterinary epidemiologists drives growth in real-time disease surveillance and smart diagnostic platforms supporting poultry health management.
Regional Momentum and Expansion
Asia-Pacific leads with over 45% of total market share, driven by expansion in poultry production and disease prevention initiatives. North America contributes nearly 25%, emphasizing partnerships in advanced veterinary diagnostics and automation. Europe holds about 20%, focusing on innovation in avian influenza, salmonella, and mycoplasma detection technologies.
Future Outlook
The Poultry Diagnostic Testing Market is projected to achieve significant growth through biosecurity strategies and precision veterinary testing innovation. Around 35% of future partnerships and mergers will focus on AI-integrated diagnostics, portable lab systems, and genetic testing solutions. Continued technological advancements will redefine accuracy, disease prevention, and operational efficiency across the global poultry health management ecosystem.
Key players in Poultry Diagnostic Testing Market include:
- IDEXX Laboratories, Inc.
- Zoetis Services LLC
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- GD Animal Health
- BioChek B.V.
- Bionote, Inc.
- Innovative Diagnostics SAS
- MEGACOR Diagnostik GmbH
- BioinGentech Biotechnologies, Inc.
- AffiniTech, Ltd.
- AgroBioTek Internacional
- Neogen Corporation
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Test
- Market Snapshot, By Disease
- Market Snapshot, By Region
- Poultry Diagnostic Testing Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Poultry Product Demand
- Poultry Disease Awareness
- Disease Management Necessity
- Advanced Diagnostic Technologies
- Restraints
- High Cost of Diagnostic Tests
- Limited Access in Rural Areas
- Lack of Skilled Personnel
- Technological Limitations
- Opportunities
- Emerging Markets Expansion
- Technological Innovations
- Increased Investment in R&D
- Growing Demand for Rapid Diagnostic Tests
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
-
Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Poultry Diagnostic Testing Market, By Test, 2021 - 2031 (USD Million)
- ELISA Test
- PCR Test
- Complement Fixation Test
- Immuno-Fluorescent Antibody Test (IFAT)
- Indirect Hemagglutination Test (IHA)
- Direct Agglutination Test
- Others
- Poultry Diagnostic Testing Market, By Disease, 2021 - 2031 (USD Million)
- Avian Salmonellosis
- Visceral Leishmaniasis (Kala-Azar)
- Avian Influenza
- Newcastle Disease
- Avian Mycoplasmosis
- Avian Pasteurellosis
- Infectious Bronchitis
- Infectious Bursal Disease
- Avian Encephalomyelitis
- Avian Reovirus
- Chicken Anemia
- Poultry Diagnostic Testing Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Poultry Diagnostic Testing Market, By Test, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- IDEXX Laboratories, Inc.
- Zoetis Services LLC
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- GD Animal Health
- BioChek B.V.
- Bionote, Inc.
- Innovative Diagnostics SAS
- MEGACOR Diagnostik GmbH
- BioinGentech Biotechnologies, Inc.
- AffiniTech, Ltd.
- AgroBioTek Internacional
- Neogen Corporation
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Company Profiles
- Analyst Views
- Future Outlook of the Market

